arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Innoviva, Inc.

INVA Health Care Biotechnology: Pharmaceutical Preparations
$21.43
Today
as of Jul 22, 16:50 ET
Last 30 days -4.42% Jun 15 → Jul 22
$21.09 $21.78 $22.46 $23.14 $23.83 Jun 15 Jun 23 Jun 30 Jul 08 Jul 15 Jul 22
Open
$22.46
High
$22.92
Low
$22.43
Volume
$830,307
Avg Vol
$818,490
Mkt Cap
$1.6B
P/E (TTM)
5.53
Beta
52w High
$25.15
52w Low
$16.52
Div Yield
Shares Out
$74M

Recent Press Releases & News last 60 days · 12 items

▸ Show all 12 press releases & news Free account →

Overview

52-week range
$17
$25
57% of range
Avg surprise (last 2)
+18.7%
Avg reaction (last 2)
-0.2%
50% positive
Latest IV / EM
37%
EM ±8.4% · $23 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.55$-0.14$0.27$0.67$1.08 Actual $0.02Actual $0.98Actual $0.46Actual $-0.55Actual $0.02Actual $0.25Actual $0.77Est $0.57Actual $1.08Actual $0.44Est $0.43 JunSepMarJunSepMar/2025Jun/2025SepMar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $0.44 $0.43 +2.3% +76.0% -0.6% earnings
Tue Sep 30, 2025Sep 2025 $1.08 financials
Wed Aug 6, 2025Jun/2025 $0.77 $0.57 +35.1% earnings
Wed May 7, 2025Mar/2025 $0.25 +0.2% earnings
Mon Sep 30, 2024Sep 2024 $0.02 financials
Sun Jun 30, 2024Jun 2024 $-0.55 financials
Sun Mar 31, 2024Mar 2024 $0.46 financials
Sat Sep 30, 2023Sep 2023 $0.98 financials
Fri Jun 30, 2023Jun 2023 $0.02 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 5, 2026Jun/2026OTHER $0.56$0.77 -27.3%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit$76M$76M$83M$73M$73M$85M
Operating income$38M$35M$49M$41M$43M$55M
Net income
EPS (diluted)$2.22$1.08$0.77$-0.74$0.02$-0.55

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$603M$551M$477M$398M$319M$305M$261M$217M
Inventory$39M$39M$38M$49M$41M$34M$34M$37M
Total current assets$773M$728M$685M$652M$582M$554M$401M$358M
Total assets$1.84B$1.64B$1.43B$1.33B$1.25B$1.30B$1.23B$1.22B
Long-term debt$258M$258M$257M$257M$257M$256M$256M$447M
Total liabilities
Total equity$1.34B$1.17B

Implied volatility — last 90 days

22%66%111%156%201% Jun 07 — IV 40% · EM ±5.6%Jun 08 — IV 29% · EM ±3.8%Jun 09 — IV 33% · EM ±4.1%Jun 10 — IV 55% · EM ±6.5%Jun 11 — IV 36% · EM ±4.0%Jun 12 — IV 39% · EM ±4.0%Jun 15 — IV 54% · EM ±3.9%Jun 16 — IV 41% · EM ±2.4%Jun 17 — IV 58% · EM ±2.4%Jun 19 — IV 28% · EM ±6.1%Jun 22 — IV 40% · EM ±8.4%Jun 23 — IV 54% · EM ±11.0%Jun 24 — IV 68% · EM ±13.5%Jun 25 — IV 55% · EM ±10.7%Jun 26 — IV 75% · EM ±14.4%Jun 29 — IV 124% · EM ±22.0%Jul 02 — IV 22% · EM ±3.6%Jul 03 — IV 23% · EM ±3.6%Jul 06 — IV 31% · EM ±4.2%Jul 07 — IV 37% · EM ±4.9%Jul 08 — IV 37% · EM ±4.7%Jul 09 — IV 185% · EM ±21.8%Jul 10 — IV 201% · EM ±22.2%Jul 20 — IV 74% · EM ±17.6%Jul 21 — IV 62% · EM ±14.5%Jul 22 — IV 37% · EM ±8.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.